| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.00e-12 | 37 | 82 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.52e-12 | 38 | 82 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 8.53e-08 | 11 | 82 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.56e-07 | 14 | 82 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 1.32e-06 | 6 | 82 | 3 | GO:0000048 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 1.32e-06 | 6 | 82 | 3 | GO:0002951 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.50e-06 | 21 | 82 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 GGTLC1 ERVK-8 ERVK-19 CPD ERVK-7 MME ERVK-21 ERVK-9 ERVK-10 GGTLC2 ERVK-24 GGT1 | 2.48e-06 | 654 | 82 | 13 | GO:0008233 |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 TRIM33 ERVK-8 ERVK-5 ERVK-19 TAB2 CPD ERVK-7 MME ERVK-21 ERVK-9 ERVK-10 ERVK-24 NR1D1 PRDM2 | 2.99e-06 | 891 | 82 | 15 | GO:0008270 |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 3.68e-06 | 8 | 82 | 3 | GO:0103068 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 5.51e-06 | 9 | 82 | 3 | GO:0036374 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.57e-05 | 37 | 82 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.75e-05 | 38 | 82 | 4 | GO:0034061 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 TRIM33 ABL2 ERVK-8 ERVK-5 ERVK-19 TAB2 CPD ERVK-7 MME ERVK-21 ERVK-9 ERVK-10 ERVK-24 NR1D1 PRDM2 | 2.27e-05 | 1189 | 82 | 16 | GO:0046914 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 3.45e-05 | 303 | 82 | 8 | GO:0003713 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 3.60e-05 | 16 | 82 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 3.78e-05 | 46 | 82 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ERVK-8 ERVK-19 ERVK-7 MME ERVK-21 ERVK-9 ERVK-10 ERVK-24 | 6.69e-05 | 430 | 82 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | threonine-type peptidase activity | 7.24e-05 | 20 | 82 | 3 | GO:0070003 | |
| GeneOntologyMolecularFunction | peptide:proton symporter activity | 9.94e-05 | 4 | 82 | 2 | GO:0015333 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 9.99e-05 | 562 | 82 | 10 | GO:0003712 | |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.15e-04 | 61 | 82 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | dipeptide transmembrane transporter activity | 1.65e-04 | 5 | 82 | 2 | GO:0071916 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 PXDN ERVK-8 ERVK-5 ERVK-19 COL6A5 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 NUP54 | 2.70e-04 | 891 | 82 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 3.14e-04 | 79 | 82 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 TRADD NCOA6 KMT2D PER2 RBM33 MAML1 CCAR1 NCOA1 TAB2 SIN3A SPEN MAML3 WDR59 PCM1 | 3.71e-04 | 1356 | 82 | 15 | GO:0060090 |
| GeneOntologyMolecularFunction | peptide transmembrane transporter activity | 5.89e-04 | 9 | 82 | 2 | GO:1904680 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 TRADD NCOA6 KMT2D PER2 RBM33 MAML1 CCAR1 NCOA1 SIN3A SPEN MAML3 WDR59 | 8.48e-04 | 1160 | 82 | 13 | GO:0030674 |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 1.63e-03 | 417 | 82 | 7 | GO:0140098 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 1.93e-03 | 16 | 82 | 2 | GO:0035673 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.39e-03 | 136 | 82 | 4 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.39e-03 | 136 | 82 | 4 | GO:0004519 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 2.43e-03 | 65 | 82 | 3 | GO:0070063 | |
| GeneOntologyMolecularFunction | histone methyltransferase binding | 2.44e-03 | 18 | 82 | 2 | GO:1990226 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 3.33e-03 | 21 | 82 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 3.56e-03 | 152 | 82 | 4 | GO:0016779 | |
| GeneOntologyMolecularFunction | transcription factor binding | 3.69e-03 | 753 | 82 | 9 | GO:0008134 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 3.99e-03 | 23 | 82 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 4.49e-03 | 262 | 82 | 5 | GO:0140097 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 4.70e-03 | 25 | 82 | 2 | GO:0015295 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 4.96e-03 | 645 | 82 | 8 | GO:0140640 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 6.23e-03 | 532 | 82 | 7 | GO:0016755 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 7.38e-03 | 417 | 82 | 6 | GO:0061629 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 7.38e-03 | 187 | 82 | 4 | GO:0016922 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.61e-07 | 13 | 82 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | cysteine biosynthetic process | 3.34e-06 | 8 | 82 | 3 | GO:0019344 | |
| GeneOntologyBiologicalProcess | peptide modification | 7.12e-06 | 10 | 82 | 3 | GO:0031179 | |
| GeneOntologyBiologicalProcess | leukotriene D4 biosynthetic process | 7.12e-06 | 10 | 82 | 3 | GO:1901750 | |
| GeneOntologyBiologicalProcess | glutathione catabolic process | 9.77e-06 | 11 | 82 | 3 | GO:0006751 | |
| GeneOntologyBiologicalProcess | leukotriene D4 metabolic process | 1.30e-05 | 12 | 82 | 3 | GO:1901748 | |
| GeneOntologyBiologicalProcess | peptide metabolic process | 2.12e-05 | 84 | 82 | 5 | GO:0006518 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 2.24e-05 | 85 | 82 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 2.24e-05 | 85 | 82 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | mRNA transport | 2.46e-05 | 145 | 82 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | syncytium formation | 2.80e-05 | 89 | 82 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | cysteine metabolic process | 3.27e-05 | 16 | 82 | 3 | GO:0006534 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 3.95e-05 | 48 | 82 | 4 | GO:0000731 | |
| GeneOntologyBiologicalProcess | negative regulation of termination of DNA-templated transcription | 4.67e-05 | 3 | 82 | 2 | GO:0060567 | |
| GeneOntologyBiologicalProcess | peptidoglycan transport | 4.67e-05 | 3 | 82 | 2 | GO:0015835 | |
| GeneOntologyBiologicalProcess | glutathione biosynthetic process | 6.58e-05 | 20 | 82 | 3 | GO:0006750 | |
| GeneOntologyBiologicalProcess | RNA transport | 7.03e-05 | 175 | 82 | 6 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 7.03e-05 | 175 | 82 | 6 | GO:0050657 | |
| GeneOntologyBiologicalProcess | sulfur amino acid biosynthetic process | 7.65e-05 | 21 | 82 | 3 | GO:0000097 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 7.72e-05 | 178 | 82 | 6 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 8.83e-05 | 22 | 82 | 3 | GO:0019184 | |
| GeneOntologyBiologicalProcess | leukotriene biosynthetic process | 8.83e-05 | 22 | 82 | 3 | GO:0019370 | |
| GeneOntologyBiologicalProcess | viral process | ERVK-6 ERVK-8 ERVK-5 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 | 9.35e-05 | 464 | 82 | 9 | GO:0016032 |
| GeneOntologyBiologicalProcess | serine family amino acid biosynthetic process | 1.31e-04 | 25 | 82 | 3 | GO:0009070 | |
| GeneOntologyBiologicalProcess | oligopeptide import across plasma membrane | 1.55e-04 | 5 | 82 | 2 | GO:0140205 | |
| GeneOntologyBiologicalProcess | dipeptide import across plasma membrane | 1.55e-04 | 5 | 82 | 2 | GO:0140206 | |
| GeneOntologyBiologicalProcess | RNA localization | 2.28e-04 | 217 | 82 | 6 | GO:0006403 | |
| GeneOntologyBiologicalProcess | regulation of termination of DNA-templated transcription | 2.32e-04 | 6 | 82 | 2 | GO:0031554 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of Notch receptor target | 3.24e-04 | 7 | 82 | 2 | GO:0007221 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription termination | 3.32e-04 | 34 | 82 | 3 | GO:0006353 | |
| GeneOntologyBiologicalProcess | peptide biosynthetic process | 3.32e-04 | 34 | 82 | 3 | GO:0043043 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 3.36e-04 | 83 | 82 | 4 | GO:0006278 | |
| GeneOntologyBiologicalProcess | modified amino acid catabolic process | 4.27e-04 | 37 | 82 | 3 | GO:0042219 | |
| GeneOntologyBiologicalProcess | dipeptide transport | 4.30e-04 | 8 | 82 | 2 | GO:0042938 | |
| GeneOntologyBiologicalProcess | dipeptide transmembrane transport | 4.30e-04 | 8 | 82 | 2 | GO:0035442 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 4.74e-04 | 249 | 82 | 6 | GO:0015931 | |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 5.38e-04 | 40 | 82 | 3 | GO:0000096 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 5.79e-04 | 41 | 82 | 3 | GO:0006691 | |
| GeneOntologyBiologicalProcess | serine family amino acid metabolic process | 6.66e-04 | 43 | 82 | 3 | GO:0009069 | |
| GeneOntologyBiologicalProcess | fatty acid derivative biosynthetic process | 1.16e-03 | 52 | 82 | 3 | GO:1901570 | |
| GeneOntologyBiologicalProcess | modified amino acid biosynthetic process | 1.16e-03 | 52 | 82 | 3 | GO:0042398 | |
| GeneOntologyBiologicalProcess | sulfur compound catabolic process | 1.23e-03 | 53 | 82 | 3 | GO:0044273 | |
| MousePheno | abnormal circulating glutathione level | 6.39e-07 | 5 | 57 | 3 | MP:0030652 | |
| MousePheno | increased circulating glutathione level | 6.39e-07 | 5 | 57 | 3 | MP:0030653 | |
| MousePheno | glutathionuria | 6.39e-07 | 5 | 57 | 3 | MP:0013730 | |
| MousePheno | increased glutathione level | 6.39e-07 | 5 | 57 | 3 | MP:0012606 | |
| MousePheno | oocyte degeneration | 7.28e-07 | 18 | 57 | 4 | MP:0009093 | |
| MousePheno | decreased circulating cysteine level | 2.22e-06 | 7 | 57 | 3 | MP:0030626 | |
| MousePheno | decreased cysteine level | 3.55e-06 | 8 | 57 | 3 | MP:0030623 | |
| MousePheno | epididymis hypoplasia | 3.55e-06 | 8 | 57 | 3 | MP:0004932 | |
| MousePheno | decreased circulating testosterone level | 4.34e-06 | 60 | 57 | 5 | MP:0002780 | |
| MousePheno | nervous | 5.31e-06 | 9 | 57 | 3 | MP:0008912 | |
| MousePheno | pigmentation phenotype | BNC1 NCOA6 PXDN PER2 GGTLC1 ALDH2 GGTLC2 SIK3 PLXNB2 PCM1 GGT1 HELLS | 6.29e-06 | 624 | 57 | 12 | MP:0001186 |
| MousePheno | abnormal coat/hair pigmentation | 7.15e-06 | 424 | 57 | 10 | MP:0002075 | |
| MousePheno | failure of copulatory plug deposition | 7.56e-06 | 10 | 57 | 3 | MP:0030983 | |
| MousePheno | seminal vesicle hypoplasia | 7.56e-06 | 10 | 57 | 3 | MP:0005148 | |
| MousePheno | ovary hypoplasia | 7.56e-06 | 10 | 57 | 3 | MP:0005158 | |
| MousePheno | abnormal circulating cysteine level | 1.04e-05 | 11 | 57 | 3 | MP:0030624 | |
| MousePheno | absent tertiary ovarian follicles | 1.04e-05 | 11 | 57 | 3 | MP:0011130 | |
| MousePheno | abnormal cysteine level | 1.79e-05 | 13 | 57 | 3 | MP:0030621 | |
| MousePheno | decreased glutathione level | 1.79e-05 | 13 | 57 | 3 | MP:0012604 | |
| MousePheno | abnormal glutathione level | 1.79e-05 | 13 | 57 | 3 | MP:0012603 | |
| MousePheno | priapism | 2.27e-05 | 14 | 57 | 3 | MP:0003415 | |
| MousePheno | abnormal circulating testosterone level | 2.28e-05 | 84 | 57 | 5 | MP:0005180 | |
| MousePheno | abnormal circulating androgen level | 2.28e-05 | 84 | 57 | 5 | MP:0009819 | |
| MousePheno | absent estrous cycle | 2.99e-05 | 44 | 57 | 4 | MP:0009009 | |
| MousePheno | abnormal copulatory plug deposition | 3.47e-05 | 16 | 57 | 3 | MP:0030982 | |
| MousePheno | decreased spleen red pulp amount | 3.47e-05 | 16 | 57 | 3 | MP:0008477 | |
| MousePheno | abnormal testosterone level | 3.54e-05 | 92 | 57 | 5 | MP:0011385 | |
| MousePheno | abnormal bile salt homeostasis | 3.89e-05 | 47 | 57 | 4 | MP:0005365 | |
| MousePheno | failure of superovulation | 5.02e-05 | 18 | 57 | 3 | MP:0031422 | |
| MousePheno | abnormal penile erection | 5.02e-05 | 18 | 57 | 3 | MP:0001379 | |
| MousePheno | decreased bone mass | 5.28e-05 | 100 | 57 | 5 | MP:0004016 | |
| MousePheno | abnormal circulating estradiol level | 5.81e-05 | 52 | 57 | 4 | MP:0005183 | |
| MousePheno | increased circulating growth hormone level | 5.95e-05 | 19 | 57 | 3 | MP:0005123 | |
| MousePheno | abnormal copulation physiology | 5.95e-05 | 19 | 57 | 3 | MP:0031627 | |
| MousePheno | abnormal circulating estrogen level | 8.35e-05 | 57 | 57 | 4 | MP:0003369 | |
| MousePheno | abnormal growth hormone level | 8.35e-05 | 57 | 57 | 4 | MP:0003968 | |
| MousePheno | small vertebrae | 9.37e-05 | 22 | 57 | 3 | MP:0004610 | |
| MousePheno | immotile sperm | 9.57e-05 | 59 | 57 | 4 | MP:0020869 | |
| MousePheno | increased growth hormone level | 1.07e-04 | 23 | 57 | 3 | MP:0005137 | |
| MousePheno | uterus hypoplasia | 1.07e-04 | 23 | 57 | 3 | MP:0001121 | |
| MousePheno | impaired ovarian folliculogenesis | 1.09e-04 | 61 | 57 | 4 | MP:0001129 | |
| MousePheno | abnormal copulation behavior | 1.22e-04 | 24 | 57 | 3 | MP:0009697 | |
| MousePheno | abnormal estrous cycle | 1.26e-04 | 120 | 57 | 5 | MP:0001927 | |
| MousePheno | abnormal thyroxine level | 1.48e-04 | 66 | 57 | 4 | MP:0005469 | |
| MousePheno | nuclear cataract | 1.56e-04 | 26 | 57 | 3 | MP:0010254 | |
| MousePheno | abnormal ovulation cycle | 1.58e-04 | 126 | 57 | 5 | MP:0009344 | |
| MousePheno | aminoaciduria | 2.18e-04 | 29 | 57 | 3 | MP:0003311 | |
| MousePheno | abnormal thyroid hormone level | 2.31e-04 | 74 | 57 | 4 | MP:0005468 | |
| MousePheno | anovulation | 3.22e-04 | 33 | 57 | 3 | MP:0008869 | |
| MousePheno | decreased circulating follicle stimulating hormone level | 3.52e-04 | 34 | 57 | 3 | MP:0002790 | |
| MousePheno | abnormal circadian behavior | 3.76e-04 | 84 | 57 | 4 | MP:0020467 | |
| MousePheno | abnormal placental labyrinth villi morphology | 4.50e-04 | 8 | 57 | 2 | MP:0011522 | |
| MousePheno | decreased circulating estradiol level | 4.90e-04 | 38 | 57 | 3 | MP:0005181 | |
| MousePheno | decreased tertiary ovarian follicle number | 5.29e-04 | 39 | 57 | 3 | MP:0011129 | |
| MousePheno | abnormal coat/ hair morphology | BNC1 PXDN PER2 PRRC2C GGTLC1 GGTLC2 SIK3 PLXNB2 PCM1 GGT1 HELLS | 5.74e-04 | 854 | 57 | 11 | MP:0000367 |
| MousePheno | decreased cornea epithelium thickness | 5.77e-04 | 9 | 57 | 2 | MP:0020855 | |
| MousePheno | decreased circulating estrogen level | 6.14e-04 | 41 | 57 | 3 | MP:0003371 | |
| MousePheno | induced hyperactivity | 6.59e-04 | 42 | 57 | 3 | MP:0008911 | |
| MousePheno | abnormal female reproductive system physiology | BNC1 NCOA6 MAGEL2 PER2 GGTLC1 NCOA1 GGTLC2 SIK3 NR1D1 GGT1 NOBOX | 7.10e-04 | 876 | 57 | 11 | MP:0003699 |
| MousePheno | increased body temperature | 7.56e-04 | 44 | 57 | 3 | MP:0005533 | |
| MousePheno | decreased follicle stimulating hormone level | 7.56e-04 | 44 | 57 | 3 | MP:0005130 | |
| MousePheno | decreased long bone epiphyseal plate size | 7.56e-04 | 44 | 57 | 3 | MP:0006396 | |
| MousePheno | abnormal tertiary ovarian follicle number | 9.18e-04 | 47 | 57 | 3 | MP:0011127 | |
| MousePheno | decreased hormone level | 9.92e-04 | 635 | 57 | 9 | MP:0014455 | |
| MousePheno | abnormal coat appearance | 1.03e-03 | 774 | 57 | 10 | MP:0001510 | |
| MousePheno | increased circulating pituitary hormone level | 1.04e-03 | 110 | 57 | 4 | MP:0005117 | |
| MousePheno | abnormal circadian sleep/wake cycle | 1.05e-03 | 12 | 57 | 2 | MP:0020478 | |
| MousePheno | decreased pituitary hormone level | 1.15e-03 | 113 | 57 | 4 | MP:0003972 | |
| MousePheno | abnormal long bone hypertrophic chondrocyte zone | 1.15e-03 | 113 | 57 | 4 | MP:0000165 | |
| MousePheno | decreased thyroxine level | 1.17e-03 | 51 | 57 | 3 | MP:0005471 | |
| MousePheno | increased core body temperature | 1.24e-03 | 13 | 57 | 2 | MP:0011016 | |
| MousePheno | abnormal corpus luteum morphology | 1.27e-03 | 116 | 57 | 4 | MP:0002679 | |
| MousePheno | female infertility | 1.32e-03 | 410 | 57 | 7 | MP:0001926 | |
| MousePheno | abnormal ovarian folliculogenesis | 1.44e-03 | 120 | 57 | 4 | MP:0001130 | |
| MousePheno | abnormal locomotor circadian rhythm | 1.44e-03 | 14 | 57 | 2 | MP:0020477 | |
| MousePheno | aciduria | 1.45e-03 | 55 | 57 | 3 | MP:0010028 | |
| MousePheno | abnormal tertiary ovarian follicle morphology | 1.61e-03 | 57 | 57 | 3 | MP:0009363 | |
| MousePheno | disproportionate dwarf | 1.61e-03 | 57 | 57 | 3 | MP:0002427 | |
| MousePheno | abnormal circadian temperature homeostasis | 1.66e-03 | 15 | 57 | 2 | MP:0011020 | |
| MousePheno | small embryonic telencephalon | 1.66e-03 | 15 | 57 | 2 | MP:0000936 | |
| MousePheno | decreased circulating hormone level | 1.67e-03 | 551 | 57 | 8 | MP:0014457 | |
| MousePheno | abnormal amino acid derivative level | 1.67e-03 | 125 | 57 | 4 | MP:0021145 | |
| MousePheno | abnormal pituitary hormone level | 1.76e-03 | 214 | 57 | 5 | MP:0003965 | |
| MousePheno | abnormal femur morphology | 1.76e-03 | 214 | 57 | 5 | MP:0000559 | |
| MousePheno | heart block | 1.77e-03 | 127 | 57 | 4 | MP:0010559 | |
| MousePheno | short femur | 1.77e-03 | 127 | 57 | 4 | MP:0003109 | |
| MousePheno | abnormal urine amino acid level | 1.78e-03 | 59 | 57 | 3 | MP:0011468 | |
| MousePheno | abnormal hindlimb stylopod morphology | 1.80e-03 | 215 | 57 | 5 | MP:0003856 | |
| MousePheno | abnormal spine curvature | 1.81e-03 | 318 | 57 | 6 | MP:0004174 | |
| MousePheno | increased pituitary hormone level | 1.82e-03 | 128 | 57 | 4 | MP:0003973 | |
| MousePheno | abnormal renal/urinary system physiology | 1.86e-03 | 695 | 57 | 9 | MP:0005502 | |
| MousePheno | decreased circulating gonadotropin level | 1.87e-03 | 60 | 57 | 3 | MP:0003363 | |
| MousePheno | abnormal cornea epithelium thickness | 1.89e-03 | 16 | 57 | 2 | MP:0020853 | |
| MousePheno | decreased femur size | 1.93e-03 | 130 | 57 | 4 | MP:0030825 | |
| MousePheno | decreased circulating insulin-like growth factor I level | 1.96e-03 | 61 | 57 | 3 | MP:0004701 | |
| MousePheno | pup cannibalization | 2.14e-03 | 17 | 57 | 2 | MP:0001385 | |
| MousePheno | diluted coat color | 2.25e-03 | 64 | 57 | 3 | MP:0000371 | |
| MousePheno | kyphosis | 2.37e-03 | 229 | 57 | 5 | MP:0000160 | |
| MousePheno | abnormal eye posterior chamber morphology | 2.40e-03 | 18 | 57 | 2 | MP:0005299 | |
| MousePheno | abnormal skin adnexa morphology | BNC1 NCOA6 PXDN PER2 PRRC2C GGTLC1 NCOA1 GGTLC2 SIK3 PLXNB2 PCM1 GGT1 HELLS | 2.43e-03 | 1341 | 57 | 13 | MP:0010678 |
| Domain | GGT_peptidase | 2.07e-06 | 7 | 74 | 3 | IPR000101 | |
| Domain | G_GLU_TRANSPEPTIDASE | 2.07e-06 | 7 | 74 | 3 | PS00462 | |
| Domain | G_glu_transpept | 2.07e-06 | 7 | 74 | 3 | PF01019 | |
| Domain | Neuroggenic_mastermind-like_N | 4.63e-05 | 3 | 74 | 2 | IPR019082 | |
| Domain | MamL-1 | 4.63e-05 | 3 | 74 | 2 | PF09596 | |
| Domain | MamL-1 | 4.63e-05 | 3 | 74 | 2 | SM01275 | |
| Domain | PTR2_1 | 4.63e-05 | 3 | 74 | 2 | PS01022 | |
| Domain | PTR2_2 | 9.24e-05 | 4 | 74 | 2 | PS01023 | |
| Domain | - | 1.45e-04 | 26 | 74 | 3 | 1.25.40.90 | |
| Domain | POT_fam | 1.54e-04 | 5 | 74 | 2 | IPR000109 | |
| Domain | PTR2 | 1.54e-04 | 5 | 74 | 2 | PF00854 | |
| Domain | IPT | 1.63e-04 | 27 | 74 | 3 | SM00429 | |
| Domain | ENTH_VHS | 2.03e-04 | 29 | 74 | 3 | IPR008942 | |
| Domain | TIG | 2.48e-04 | 31 | 74 | 3 | PF01833 | |
| Domain | IPT | 2.73e-04 | 32 | 74 | 3 | IPR002909 | |
| Domain | Ntn_hydrolases_N | 2.99e-04 | 33 | 74 | 3 | IPR029055 | |
| Domain | RNA_pol_II-bd | 3.21e-04 | 7 | 74 | 2 | IPR006903 | |
| Domain | CTD_bind | 3.21e-04 | 7 | 74 | 2 | PF04818 | |
| Domain | RPR | 4.27e-04 | 8 | 74 | 2 | SM00582 | |
| Domain | CID | 4.27e-04 | 8 | 74 | 2 | PS51391 | |
| Domain | CID_dom | 4.27e-04 | 8 | 74 | 2 | IPR006569 | |
| Domain | zf-CCHC | 3.71e-03 | 23 | 74 | 2 | PF00098 | |
| Domain | ArfGap | 5.87e-03 | 29 | 74 | 2 | SM00105 | |
| Domain | ArfGap | 5.87e-03 | 29 | 74 | 2 | PF01412 | |
| Domain | ARFGAP | 5.87e-03 | 29 | 74 | 2 | PS50115 | |
| Domain | ArfGAP | 5.87e-03 | 29 | 74 | 2 | IPR001164 | |
| Domain | ZF_PHD_2 | 6.37e-03 | 95 | 74 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 6.55e-03 | 96 | 74 | 3 | PS01359 | |
| Domain | PAS | 7.11e-03 | 32 | 74 | 2 | SM00091 | |
| Domain | PAS | 8.00e-03 | 34 | 74 | 2 | IPR000014 | |
| Domain | PAS | 8.00e-03 | 34 | 74 | 2 | PS50112 | |
| Domain | Ig_E-set | 8.17e-03 | 104 | 74 | 3 | IPR014756 | |
| Domain | ZF_CCHC | 8.47e-03 | 35 | 74 | 2 | PS50158 | |
| Domain | Cadherin_tail | 9.43e-03 | 37 | 74 | 2 | PF15974 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 8.95e-06 | 70 | 57 | 5 | M938 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.94e-05 | 82 | 57 | 5 | MM15922 | |
| Pathway | REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING | 3.38e-05 | 16 | 57 | 3 | MM14680 | |
| Pathway | REACTOME_HEME_SIGNALING | 4.44e-05 | 49 | 57 | 4 | M41832 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 7.03e-05 | 55 | 57 | 4 | M27145 | |
| Pathway | WP_EICOSANOID_SYNTHESIS | 9.14e-05 | 22 | 57 | 3 | MM15961 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.06e-04 | 61 | 57 | 4 | M39540 | |
| Pathway | WP_OXYLIPINS_PATHWAYS | 1.19e-04 | 24 | 57 | 3 | MM17249 | |
| Pathway | REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX | 1.35e-04 | 25 | 57 | 3 | MM14858 | |
| Pathway | REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION | 1.53e-04 | 26 | 57 | 3 | MM15190 | |
| Pathway | WP_GLUTATHIONE_METABOLISM | 1.71e-04 | 27 | 57 | 3 | MM15908 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_LIPOXYGENASES_LOX | 3.14e-04 | 33 | 57 | 3 | MM15963 | |
| Pathway | WP_GLUTATHIONE_AND_ONECARBON_METABOLISM | 3.74e-04 | 35 | 57 | 3 | MM15815 | |
| Pathway | REACTOME_GLUTATHIONE_CONJUGATION | 4.78e-04 | 38 | 57 | 3 | MM14600 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 5.17e-04 | 39 | 57 | 3 | MM15695 | |
| Pathway | REACTOME_MITOCHONDRIAL_BIOGENESIS | 6.05e-04 | 96 | 57 | 4 | M26973 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 7.08e-04 | 10 | 57 | 2 | MM15535 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 7.88e-04 | 45 | 57 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 8.41e-04 | 46 | 57 | 3 | MM15971 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_NFKB_SIGNALING_PATHWAY | 8.63e-04 | 11 | 57 | 2 | M47493 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 8.96e-04 | 47 | 57 | 3 | M7946 | |
| Pathway | PID_HES_HEY_PATHWAY | 9.53e-04 | 48 | 57 | 3 | M288 | |
| Pathway | WP_EXERCISEINDUCED_CIRCADIAN_REGULATION | 1.01e-03 | 49 | 57 | 3 | MM15870 | |
| Pathway | REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.03e-03 | 12 | 57 | 2 | M27159 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.03e-03 | 12 | 57 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.03e-03 | 12 | 57 | 2 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.22e-03 | 13 | 57 | 2 | M47534 | |
| Pathway | KEGG_CIRCADIAN_RHYTHM_MAMMAL | 1.22e-03 | 13 | 57 | 2 | M18009 | |
| Pathway | REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE | 1.22e-03 | 297 | 57 | 6 | M27050 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.31e-03 | 118 | 57 | 4 | M27316 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 1.31e-03 | 301 | 57 | 6 | MM15983 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_NEF_TO_TNF_NFKB_SIGNALING_PATHWAY | 1.42e-03 | 14 | 57 | 2 | M47567 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.42e-03 | 14 | 57 | 2 | M27808 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_TNF_NFKB_SIGNALING_PATHWAY | 1.63e-03 | 15 | 57 | 2 | M47566 | |
| Pathway | PID_NOTCH_PATHWAY | 1.74e-03 | 59 | 57 | 3 | M17 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 1.82e-03 | 60 | 57 | 3 | M41830 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNF_JNK_SIGNALING_PATHWAY | 1.86e-03 | 16 | 57 | 2 | M47569 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.86e-03 | 16 | 57 | 2 | M27121 | |
| Pathway | PID_CIRCADIAN_PATHWAY | 1.86e-03 | 16 | 57 | 2 | M95 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TNF_NFKB_SIGNALING_PATHWAY | 1.86e-03 | 16 | 57 | 2 | M47453 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.88e-03 | 219 | 57 | 5 | MM14838 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.91e-03 | 61 | 57 | 3 | MM14861 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 2.36e-03 | 18 | 57 | 2 | MM15034 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 2.36e-03 | 18 | 57 | 2 | M26942 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.36e-03 | 18 | 57 | 2 | MM14775 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVK-8 ERVK-5 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ERVK-10 ERVK-24 | 1.62e-12 | 94 | 84 | 9 | 21542922 |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 3.17e-11 | 4 | 84 | 4 | 10469592 | |
| Pubmed | 3.17e-11 | 4 | 84 | 4 | 7983737 | ||
| Pubmed | 5.69e-11 | 12 | 84 | 5 | 14557543 | ||
| Pubmed | TRERF1 PCF11 TRIM33 NCOA6 KMT2D RBM33 BICRA PRRC2C MAML1 CCAR1 NCOA1 ASXL2 SIN3A SPEN PCM1 PRDM2 SCAF4 HELLS | 1.21e-10 | 1103 | 84 | 18 | 34189442 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.58e-10 | 5 | 84 | 4 | 12629516 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TRERF1 NCOA6 CRTC3 ZNF469 MAGEL2 BICRA AGFG1 RNF38 NUMB SIN3A TSC22D2 SPEN | 5.55e-10 | 430 | 84 | 12 | 35044719 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 TRIM33 NCOA6 KMT2D BICRA MAML1 NCOA1 ASXL2 SPEN PRDM2 NUP54 | 9.11e-10 | 351 | 84 | 11 | 38297188 |
| Pubmed | TRERF1 PCF11 TRIM33 NCOA6 KMT2D RBM33 BICRA PRRC2C MAML1 CCAR1 NCOA1 ASXL2 SIN3A SPEN PCM1 PRDM2 SCAF4 NUP54 HELLS | 1.05e-09 | 1429 | 84 | 19 | 35140242 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | PCF11 TRIM33 NCOA6 CRTC3 KMT2D RBM33 PRRC2C MAML1 AGFG2 ALDH2 MAML3 NUP54 | 1.10e-09 | 457 | 84 | 12 | 32344865 |
| Pubmed | Human lung expresses unique gamma-glutamyl transpeptidase transcripts. | 1.36e-08 | 3 | 84 | 3 | 7689219 | |
| Pubmed | 1.86e-08 | 268 | 84 | 9 | 33640491 | ||
| Pubmed | 9.44e-08 | 18 | 84 | 4 | 18664271 | ||
| Pubmed | Lung lining fluid glutathione attenuates IL-13-induced asthma. | 1.35e-07 | 5 | 84 | 3 | 18063838 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 10940879 | ||
| Pubmed | Cataract development in gamma-glutamyl transpeptidase-deficient mice. | 1.35e-07 | 5 | 84 | 3 | 11095909 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 7641802 | ||
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 23615310 | ||
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 9627710 | ||
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 12453183 | ||
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 11003618 | ||
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 10392451 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.35e-07 | 5 | 84 | 3 | 11401426 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 2891746 | ||
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 19850887 | ||
| Pubmed | Reversible skeletal abnormalities in gamma-glutamyl transpeptidase-deficient mice. | 1.35e-07 | 5 | 84 | 3 | 12810527 | |
| Pubmed | Growth retardation and cysteine deficiency in gamma-glutamyl transpeptidase-deficient mice. | 1.35e-07 | 5 | 84 | 3 | 8755578 | |
| Pubmed | Reproductive defects in gamma-glutamyl transpeptidase-deficient mice. | 1.35e-07 | 5 | 84 | 3 | 11089562 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 28660214 | ||
| Pubmed | Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice. | 1.35e-07 | 5 | 84 | 3 | 12468440 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 26977590 | ||
| Pubmed | Gamma-glutamyl transferase deficiency results in lung oxidant stress in normoxia. | 1.35e-07 | 5 | 84 | 3 | 12225953 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 7775425 | ||
| Pubmed | Cloning of cDNA and genomic structure of the mouse gamma-glutamyl transpeptidase-encoding gene. | 1.35e-07 | 5 | 84 | 3 | 8566783 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 30591459 | ||
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 9139708 | ||
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 20622017 | ||
| Pubmed | Accelerated methylmercury elimination in gamma-glutamyl transpeptidase-deficient mice. | 1.35e-07 | 5 | 84 | 3 | 9546365 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 11795900 | ||
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 7485380 | ||
| Pubmed | Accumulation of DNA damage in the organs of mice deficient in gamma-glutamyltranspeptidase. | 1.35e-07 | 5 | 84 | 3 | 10751614 | |
| Pubmed | Type VI RNA is the major gamma-glutamyl transpeptidase RNA in the mouse small intestine. | 1.35e-07 | 5 | 84 | 3 | 7523374 | |
| Pubmed | Cardio-reno-hepatic interactions in acute heart failure: the role of γ-glutamyl transferase. | 1.35e-07 | 5 | 84 | 3 | 24698228 | |
| Pubmed | Inhibiting lung lining fluid glutathione metabolism with GGsTop as a novel treatment for asthma. | 1.35e-07 | 5 | 84 | 3 | 25132819 | |
| Pubmed | Characterization of the dwg mutations: dwg and dwg(Bayer) are new mutant alleles of the Ggt1 gene. | 1.35e-07 | 5 | 84 | 3 | 19760322 | |
| Pubmed | 1.35e-07 | 5 | 84 | 3 | 10474818 | ||
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 14634009 | ||
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 17363454 | ||
| Pubmed | Six mRNAs with different 5' ends are encoded by a single gamma-glutamyltransferase gene in mouse. | 2.70e-07 | 6 | 84 | 3 | 8101000 | |
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 8663190 | ||
| Pubmed | Mapping of human gamma-glutamyl transpeptidase genes on chromosome 22 and other human autosomes. | 2.70e-07 | 6 | 84 | 3 | 8104871 | |
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 11463821 | ||
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 25326709 | ||
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 15063128 | ||
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 12163373 | ||
| Pubmed | 2.70e-07 | 6 | 84 | 3 | 22242126 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRERF1 PCF11 NCOA6 KMT2D MDN1 CCAR1 SIN3A NR1D1 SPEN PCM1 PRDM2 SCAF4 | 3.54e-07 | 774 | 84 | 12 | 15302935 |
| Pubmed | 4.72e-07 | 7 | 84 | 3 | 27775020 | ||
| Pubmed | Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation. | 4.72e-07 | 7 | 84 | 3 | 32284594 | |
| Pubmed | Defective epidermal growth factor gene expression in mice with polycystic kidney disease. | 4.72e-07 | 7 | 84 | 3 | 1968405 | |
| Pubmed | 4.72e-07 | 7 | 84 | 3 | 36685533 | ||
| Pubmed | 1.13e-06 | 9 | 84 | 3 | 9303539 | ||
| Pubmed | 1.57e-06 | 35 | 84 | 4 | 24515614 | ||
| Pubmed | 1.61e-06 | 10 | 84 | 3 | 12970426 | ||
| Pubmed | 1.61e-06 | 10 | 84 | 3 | 23863468 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PCF11 TRIM33 NCOA6 RBM33 BICRA PRRC2C AGFG1 CCAR1 SPEN PCM1 SCAF4 HELLS | 3.12e-06 | 954 | 84 | 12 | 36373674 |
| Pubmed | 3.28e-06 | 638 | 84 | 10 | 31182584 | ||
| Pubmed | 4.85e-06 | 14 | 84 | 3 | 12482968 | ||
| Pubmed | 4.85e-06 | 14 | 84 | 3 | 18357469 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 5.14e-06 | 180 | 84 | 6 | 35198878 | |
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 21628550 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 19926610 | ||
| Pubmed | 5.76e-06 | 2 | 84 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 5.76e-06 | 2 | 84 | 2 | 9460924 | |
| Pubmed | Salt-inducible kinase 3 regulates the mammalian circadian clock by destabilizing PER2 protein. | 5.76e-06 | 2 | 84 | 2 | 29227248 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NCOA6 CRTC3 ABL2 MDN1 PRRC2C AGFG1 NUMB TAB2 SIK3 WDR59 PCM1 | 7.20e-06 | 861 | 84 | 11 | 36931259 |
| Pubmed | 7.34e-06 | 549 | 84 | 9 | 38280479 | ||
| Pubmed | Gene dosage in the developing and adult brain in a mouse model of 22q11 deletion syndrome. | 1.08e-05 | 18 | 84 | 3 | 17097888 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPN3 NCOA6 KMT2D LLGL2 MDN1 REPS1 PER2 BICRA MAML1 SPEN PLXNB2 WDR59 | 1.37e-05 | 1105 | 84 | 12 | 35748872 |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 1.50e-05 | 20 | 84 | 3 | 29785026 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 12386158 | ||
| Pubmed | REV-ERBα and REV-ERBβ function as key factors regulating Mammalian Circadian Output. | 1.73e-05 | 3 | 84 | 2 | 31308426 | |
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 10516026 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 9971820 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 34705514 | ||
| Pubmed | 1.73e-05 | 3 | 84 | 2 | 31073693 | ||
| Pubmed | The candidate splicing factor Sfswap regulates growth and patterning of inner ear sensory organs. | 3.39e-05 | 26 | 84 | 3 | 24391519 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 30195196 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 22184247 | ||
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 9446614 | ||
| Pubmed | Adiponectin induces A20 expression in adipose tissue to confer metabolic benefit. | 3.45e-05 | 4 | 84 | 2 | 25190567 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 21366347 | ||
| Pubmed | The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. | 3.45e-05 | 4 | 84 | 2 | 12905028 | |
| Pubmed | Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β. | 3.45e-05 | 4 | 84 | 2 | 22460952 | |
| Pubmed | 3.45e-05 | 4 | 84 | 2 | 10613896 | ||
| Pubmed | 3.81e-05 | 27 | 84 | 3 | 18478268 | ||
| Pubmed | 3.94e-05 | 78 | 84 | 4 | 28611094 | ||
| Pubmed | Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. | 4.75e-05 | 29 | 84 | 3 | 22424930 | |
| Pubmed | 5.74e-05 | 5 | 84 | 2 | 22405069 | ||
| Pubmed | Circadian clock component REV-ERBα controls homeostatic regulation of pulmonary inflammation. | 5.74e-05 | 5 | 84 | 2 | 29533925 | |
| Interaction | TLE3 interactions | TRERF1 INTS10 CRTC3 KMT2D MAML1 MASTL AGFG2 CCAR1 NCOA1 ASXL2 SPEN SCAF4 NUP54 | 1.99e-09 | 376 | 78 | 13 | int:TLE3 |
| Interaction | SP7 interactions | TRERF1 PCF11 TRIM33 NCOA6 KMT2D RBM33 BICRA MAML1 CCAR1 NCOA1 SIN3A SCAF4 | 2.00e-09 | 304 | 78 | 12 | int:SP7 |
| Interaction | NUP35 interactions | PCF11 TRIM33 NCOA6 CRTC3 KMT2D RBM33 PRRC2C MAML1 AGFG2 ALDH2 MAML3 NUP54 | 7.98e-08 | 424 | 78 | 12 | int:NUP35 |
| Interaction | CEBPA interactions | TRERF1 PCF11 TRIM33 NCOA6 KMT2D RBM33 BICRA PRRC2C MAML1 CCAR1 NCOA1 ASXL2 SIN3A SPEN PCM1 PRDM2 SCAF4 HELLS | 9.32e-07 | 1245 | 78 | 18 | int:CEBPA |
| Interaction | EGR2 interactions | 4.46e-06 | 171 | 78 | 7 | int:EGR2 | |
| Interaction | AR interactions | TRERF1 PCF11 TRIM33 NCOA6 KMT2D ABL2 MDN1 RBM33 MAML1 CCAR1 NCOA1 TAB2 SIN3A MME PCM1 | 5.15e-06 | 992 | 78 | 15 | int:AR |
| Interaction | CRX interactions | 6.25e-06 | 254 | 78 | 8 | int:CRX | |
| Interaction | QPRT interactions | 1.85e-05 | 84 | 78 | 5 | int:QPRT | |
| Interaction | SUPT5H interactions | 2.78e-05 | 408 | 78 | 9 | int:SUPT5H | |
| Interaction | SMG7 interactions | 3.23e-05 | 319 | 78 | 8 | int:SMG7 | |
| Interaction | SEM1 interactions | 3.92e-05 | 162 | 78 | 6 | int:SEM1 | |
| Interaction | GGTLC2 interactions | 4.43e-05 | 3 | 78 | 2 | int:GGTLC2 | |
| Interaction | GGT2P interactions | 4.43e-05 | 3 | 78 | 2 | int:GGT2P | |
| Interaction | ALG13 interactions | 7.72e-05 | 183 | 78 | 6 | int:ALG13 | |
| Interaction | TBXT interactions | 8.75e-05 | 116 | 78 | 5 | int:TBXT | |
| Interaction | HNF4A interactions | 9.44e-05 | 275 | 78 | 7 | int:HNF4A | |
| Interaction | GGT1 interactions | 1.21e-04 | 25 | 78 | 3 | int:GGT1 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 5.58e-06 | 13 | 50 | 3 | 564 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.16e-03 | 25 | 50 | 2 | 775 | |
| GeneFamily | ArfGAPs | 3.75e-03 | 33 | 50 | 2 | 395 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.97e-03 | 34 | 50 | 2 | 487 | |
| Coexpression | OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN | 1.43e-06 | 281 | 75 | 8 | M7089 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 1.52e-06 | 196 | 75 | 7 | M5381 | |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | TRIM33 NCOA6 ABL2 PER2 CCNA1 RNF38 NCOA1 NUMB TSC22D2 SIK3 NR1D1 NFAT5 | 3.56e-06 | 822 | 75 | 12 | M6782 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TRERF1 PCF11 TRIM33 KMT2D RBM33 AGFG1 RNF38 NCOA1 TAB2 ASXL2 SIN3A SIK3 SPEN NFAT5 PCM1 PRDM2 | 3.93e-06 | 1492 | 75 | 16 | M40023 |
| Coexpression | GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP | 2.12e-05 | 196 | 75 | 6 | M3243 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 2.38e-05 | 200 | 75 | 6 | M5851 | |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN | 2.38e-05 | 200 | 75 | 6 | M8485 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PCF11 TRIM33 MDN1 PRRC2C AGFG1 NCOA1 NUMB TAB2 TSC22D2 SIK3 SPEN | 3.08e-05 | 856 | 75 | 11 | M4500 |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN | 6.95e-05 | 149 | 75 | 5 | M6683 | |
| Coexpression | ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN | 1.05e-04 | 85 | 75 | 4 | M41085 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.08e-07 | 193 | 75 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | (7)_Epithelial-I_(AT1)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.93e-07 | 196 | 75 | 6 | 150554fa06868d29b0608189862eef6505ba757f | |
| ToppCell | AT1_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.01e-06 | 162 | 75 | 5 | ae2ba4f21f6f6c512006fa531d670b88be7c04c9 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 182 | 75 | 5 | cfba75c1ffc39ac76db9e8e27394731942882b30 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 182 | 75 | 5 | d836bfdc298ecd3558a973e393a329eb8bd59d79 | |
| ToppCell | droplet-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 182 | 75 | 5 | 7e7c7a26460d3003cdf0c0ffb96208a566aa09a7 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.77e-05 | 191 | 75 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.82e-05 | 192 | 75 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-05 | 195 | 75 | 5 | 07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-05 | 195 | 75 | 5 | b65511770ed67f7447847e2187555b362988af45 | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.01e-05 | 196 | 75 | 5 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-05 | 198 | 75 | 5 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.11e-05 | 198 | 75 | 5 | 93cc01d91ffc543fd1a717ef47e02e532b50b665 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.16e-05 | 199 | 75 | 5 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-05 | 199 | 75 | 5 | fde8e3ba19d19069a4d3b8db55bfe6220cf634d5 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.16e-05 | 199 | 75 | 5 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.16e-05 | 199 | 75 | 5 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.21e-05 | 200 | 75 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Parenchyma_Control_(B.)|World / Sample group, Lineage and Cell type | 2.21e-05 | 200 | 75 | 5 | 220b6e5f936b3d08b031d6cabc5793213b98b8e2 | |
| ToppCell | Control-CD8+_T_activated|World / Disease group and Cell class | 4.89e-05 | 119 | 75 | 4 | 83c3e2bb71b947facbfbef635550901f33c8c26a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-04 | 159 | 75 | 4 | 60b1f4dce2ce0911160fda17f137c064da31e2eb | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 160 | 75 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 160 | 75 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-04 | 165 | 75 | 4 | a379fa981db51bec01adea7b1e55e133e15ec383 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-04 | 169 | 75 | 4 | 0589f39d8e9468e42d25d30ff70bb7cb8b921628 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-04 | 175 | 75 | 4 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 2.21e-04 | 176 | 75 | 4 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.21e-04 | 176 | 75 | 4 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.26e-04 | 177 | 75 | 4 | f10f77130dbb2c0ad1b436ceb4fb1deac2b0267c | |
| ToppCell | facs-Kidney-nan-18m|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 177 | 75 | 4 | d4cd54c07f1e51b5485270348fb7195d53465027 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-04 | 178 | 75 | 4 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.41e-04 | 180 | 75 | 4 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.41e-04 | 180 | 75 | 4 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.41e-04 | 180 | 75 | 4 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-04 | 181 | 75 | 4 | 65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-04 | 181 | 75 | 4 | eaac7d58117eddfff06b25521efc431c1351d592 | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 2.52e-04 | 182 | 75 | 4 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-04 | 183 | 75 | 4 | 9d5a363fbe6f0a1668c9d584df65ee1c283349c7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-04 | 183 | 75 | 4 | c5caac6ed6c8d67f5c336281d9fd903976509445 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 184 | 75 | 4 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.62e-04 | 184 | 75 | 4 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | Control-CD8+_T_activated|Control / Disease group and Cell class | 2.62e-04 | 184 | 75 | 4 | b86cc48b744b3206880ec1373fe6068e14bf9680 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 2.68e-04 | 185 | 75 | 4 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 2.68e-04 | 185 | 75 | 4 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CF-Myeloid-cDC|CF / Disease state, Lineage and Cell class | 2.68e-04 | 185 | 75 | 4 | 7f3d118845ff9f5f525796b0bbc6532a8ee323ab | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.73e-04 | 186 | 75 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.73e-04 | 186 | 75 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-04 | 187 | 75 | 4 | 9aa411ae9b5a923378a5daebb8bb2fc2613f2510 | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 2.79e-04 | 187 | 75 | 4 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | Control-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 2.79e-04 | 187 | 75 | 4 | 3a032432f780525f4f4c2a358897d9989b1ecae7 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.85e-04 | 188 | 75 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | AT1-AT2_cells-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.85e-04 | 188 | 75 | 4 | be710bc957118cf426dd71c2d57e6f1b41c9a467 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.90e-04 | 189 | 75 | 4 | a59025e82fabd9d60e2438dee85b2644478cc7c8 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-04 | 189 | 75 | 4 | 09dd2b3d89416192e84abe302a6237b8f3fdcb6e | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.08e-04 | 192 | 75 | 4 | 6bba80887d6f64cf913a5c22f62baaddda417ce0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 194 | 75 | 4 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-Goblet_(subsegmental)_L.0.4.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-04 | 195 | 75 | 4 | 2a9a36df1dbc4eac77a8ddbe939ec8a8d6c41464 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-04 | 195 | 75 | 4 | 576142b4e75457c0973051bccc4163bd624496af | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-04 | 195 | 75 | 4 | 8f151066ad3ebd9661ea0b733f03c2ce1518f9ad | |
| ToppCell | AT1_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.27e-04 | 195 | 75 | 4 | 792d6a49b0a875a00569071183d195287a9925c5 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.33e-04 | 196 | 75 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.33e-04 | 196 | 75 | 4 | b74dbdfc8d9b85d7cae5c6a49b56347b15ce16e1 | |
| ToppCell | AT1|World / shred by cell class for parenchyma | 3.33e-04 | 196 | 75 | 4 | 2bc487f8a109a6961ebff111dec79c2227ea60ac | |
| ToppCell | BL-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.33e-04 | 196 | 75 | 4 | f64d7fed31e418c55fe946744d78c3cbecec9bbf | |
| ToppCell | distal-1-Epithelial-Alveolar_Epithelial_Type_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.40e-04 | 197 | 75 | 4 | d44b7dc7c6416ed9466889374c3ae39f43ac8bb6 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.40e-04 | 197 | 75 | 4 | 311438418f3d697e54222da111014c887fd815f5 | |
| ToppCell | AT1_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 3.40e-04 | 197 | 75 | 4 | 80d81be244c94c435accb643449b4ce6a3462c7f | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|World / Lineage, cell class and subclass | 3.46e-04 | 198 | 75 | 4 | 2528062d1646746b2e7d6b0ec38f8cfabf3df18f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.46e-04 | 198 | 75 | 4 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.46e-04 | 198 | 75 | 4 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.46e-04 | 198 | 75 | 4 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | moderate-Myeloid-Neutrophil|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.46e-04 | 198 | 75 | 4 | a6306dac34af5783f3a734ef1eaa7a0c03267b4f | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.46e-04 | 198 | 75 | 4 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-04 | 199 | 75 | 4 | 5b6feacb0ca92c3fc6b327be978320426dcf6f68 | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.53e-04 | 199 | 75 | 4 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | medial-2-Epithelial-Alveolar_Epithelial_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-04 | 199 | 75 | 4 | 456460c761e26ed4b1d88d9bee4d2a7c9bd9d416 | |
| ToppCell | control-CD163+_Monocytes_(Sample_ID1_d7)|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.53e-04 | 199 | 75 | 4 | 933201d32eda12a89660bdbae9114a95cc428a38 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.53e-04 | 199 | 75 | 4 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-04 | 199 | 75 | 4 | 5263338242f95c04690d0795749ccc20b0d19f7a | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.53e-04 | 199 | 75 | 4 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-04 | 199 | 75 | 4 | fbd39d34636137d1b877dd8815d58f124990136b | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-04 | 199 | 75 | 4 | c11365653c69a5dfb37946231f8af05149a61a71 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-04 | 199 | 75 | 4 | 6977f939ddbc47d4921f36c0a61a205259fe1284 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-04 | 199 | 75 | 4 | e1190b1c2d21fed313bb58e24d0e6365de6e6599 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-04 | 200 | 75 | 4 | 8c4c396e99be6131a8fa60d86214d561031b12bf | |
| ToppCell | distal-2-Epithelial-Alveolar_Epithelial_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.60e-04 | 200 | 75 | 4 | 313ec1e53bd738a9cb48dc5b946261156f99f44b | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.60e-04 | 200 | 75 | 4 | c6f211bbadd0c9be776c58807249e06764df47dc | |
| ToppCell | distal-3-Epithelial-Alveolar_Epithelial_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.60e-04 | 200 | 75 | 4 | ff64454a08ae8d4cc6e8f0392558460020844bbc | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT1|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.60e-04 | 200 | 75 | 4 | b746dcc94814bcbca63c71e6451a9c5f084bcfaf | |
| ToppCell | mild-Classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.60e-04 | 200 | 75 | 4 | c8b80d4e7f70c66cbbdd0665821bcd5db69c7d35 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.60e-04 | 200 | 75 | 4 | 5f7e8d8b05c90a10313775f9f126eb4ab0fe4f67 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.60e-04 | 200 | 75 | 4 | ccd0edd483728279fe15d64be3a39e8636bf2eeb | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.60e-04 | 200 | 75 | 4 | cbe3e107ac16c17687d73ebb04c39d51aba1fa98 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.60e-04 | 200 | 75 | 4 | e3a80626941363bfc9d97ef906d38c97080aecb1 | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.60e-04 | 200 | 75 | 4 | 9e3e13a68bc1110fa000ec2d80f4c654ddbce17e | |
| Drug | Isocorydine (+) [475-67-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.17e-06 | 196 | 76 | 7 | 2780_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 4.17e-06 | 196 | 76 | 7 | 2667_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 4.45e-06 | 198 | 76 | 7 | 4343_UP | |
| Drug | Phe-gly | 4.56e-06 | 73 | 76 | 5 | CID000098207 | |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 4.60e-06 | 199 | 76 | 7 | 5321_DN | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 5.48e-07 | 7 | 75 | 3 | DOID:5022 (biomarker_via_orthology) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 8.75e-07 | 8 | 75 | 3 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | fish oil supplement exposure measurement, high density lipoprotein cholesterol measurement | 1.33e-04 | 7 | 75 | 2 | EFO_0004612, EFO_0600007 | |
| Disease | obesity (implicated_via_orthology) | 2.24e-04 | 215 | 75 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | 3.79e-04 | 1074 | 75 | 10 | C0006142 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 4.86e-04 | 60 | 75 | 3 | EFO_0020690 | |
| Disease | vision disorder | 7.48e-04 | 16 | 75 | 2 | MONDO_0021084 | |
| Disease | hair colour measurement | 9.63e-04 | 615 | 75 | 7 | EFO_0007822 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 1.06e-03 | 19 | 75 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | renal system measurement | 1.18e-03 | 20 | 75 | 2 | EFO_0004742 | |
| Disease | Arthrogryposis | 1.30e-03 | 21 | 75 | 2 | C0003886 | |
| Disease | visceral adipose tissue measurement, body mass index | 1.43e-03 | 87 | 75 | 3 | EFO_0004340, EFO_0004765 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.71e-03 | 200 | 75 | 4 | EFO_0004611, EFO_0020945 | |
| Disease | metabolic syndrome | 1.71e-03 | 200 | 75 | 4 | EFO_0000195 | |
| Disease | multisite chronic pain | 1.85e-03 | 95 | 75 | 3 | EFO_0010100 | |
| Disease | brain cancer (implicated_via_orthology) | 1.99e-03 | 26 | 75 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | 2.20e-03 | 525 | 75 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 2.20e-03 | 525 | 75 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 2.24e-03 | 527 | 75 | 6 | C1458155 | |
| Disease | 1,5 anhydroglucitol measurement | 2.48e-03 | 29 | 75 | 2 | EFO_0008009 | |
| Disease | Breast Carcinoma | 2.49e-03 | 538 | 75 | 6 | C0678222 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QFVQEPQAQQSRPFP | 31 | Q8N9T2 | |
| FSFTPAQQEANLVPP | 701 | P42684 | |
| APQTTFGVQTQPQPQ | 231 | Q8IX12 | |
| VSVFPQAGAFAPQPL | 596 | Q9H201 | |
| PPFNDETPQQVFQNI | 776 | Q96GX5 | |
| QPAFPNIGQNGVLFP | 466 | Q01954 | |
| RQHQQPFQVSPQPFL | 591 | Q76L83 | |
| QSPLPFTQPGPAFNQ | 501 | Q96EV2 | |
| PAFNQQGQQPVFPRE | 511 | Q96EV2 | |
| VNSIQPSLFQGPNAP | 326 | Q9NVR2 | |
| SNQPGPFQFSQAPQP | 511 | O60393 | |
| PFQFSQAPQPPLFQS | 516 | O60393 | |
| PQYQDPTQGSFPQQV | 671 | Q92585 | |
| NGQPVPFQQPKHFTG | 206 | Q9NRZ9 | |
| QAYPVAFPPQDGVQQ | 4271 | Q9NU22 | |
| EQPFQGAPPSQKAVQ | 646 | Q9UJ55 | |
| GFQPFVLVQCQPPAV | 576 | Q6P1M3 | |
| FSQPPAQQQIPSGSF | 1061 | Q96JK9 | |
| PQNQPFVFSLGTGQV | 71 | P26885 | |
| PLPPPMQSFQGNQFQ | 26 | Q6JVE5 | |
| GTPNLPQAFFPSQPQ | 916 | O15055 | |
| FPTQPVNLFNIPGFT | 1116 | Q15154 | |
| IPSFPAQPQGQAVAR | 101 | A0A0J9YX94 | |
| LGRSPPNVQFTFQQP | 881 | O15031 | |
| VLPQASQGQPFLSQP | 1161 | Q6ZU69 | |
| TNEFGVPPSPANFIQ | 86 | Q9BX51 | |
| NQIVFPAGILQPPFF | 551 | P08473 | |
| TNEFGVPPSPANFIQ | 86 | Q14390 | |
| QPQYTVFVKENNPPG | 456 | Q9Y5H7 | |
| AQPPQQGLFQPQVAL | 1201 | O94916 | |
| FLPPSQPNGNIQVYQ | 1706 | Q9UMZ3 | |
| NNNIPPVEFTQENPF | 156 | Q7Z3B4 | |
| AQPVAFGQGQQFLPV | 1226 | O94913 | |
| FGQGQQFLPVHPQNP | 1231 | O94913 | |
| QFLPVHPQNPGFVQN | 1236 | O94913 | |
| NTPNFPQPQQELFVA | 441 | Q9H158 | |
| QQQPQGIRPQFTAPT | 296 | Q14686 | |
| TPPQQFQPAGTDQVC | 296 | Q86WN1 | |
| SPLVGFSQFPQQLTP | 261 | P20393 | |
| QAPQQTGAFPIQPFV | 616 | P87889 | |
| TGAFPIQPFVPQGFQ | 621 | P87889 | |
| IQPFVPQGFQGQQPP | 626 | P87889 | |
| PQGFQGQQPPLSQVF | 631 | P87889 | |
| QAPQQTGAFPIQPFV | 616 | Q9YNA8 | |
| IQPFVPHGFQGQQPP | 626 | Q9YNA8 | |
| PHGFQGQQPPLSQVF | 631 | Q9YNA8 | |
| QAPQQTGAFPIQPFV | 616 | P62683 | |
| TGAFPIQPFVPQGFQ | 621 | P62683 | |
| IQPFVPQGFQGQQPP | 626 | P62683 | |
| PQGFQGQQPPLSQVF | 631 | P62683 | |
| QAPQQTGAFPIQPFV | 616 | P63145 | |
| TGAFPIQPFVPQGFQ | 621 | P63145 | |
| IQPFVPQGFQGQQPP | 626 | P63145 | |
| PQGFQGQQPPLSQVF | 631 | P63145 | |
| TGAFPVQLFVPQGFQ | 621 | Q9HDB9 | |
| VQLFVPQGFQGQQPL | 626 | Q9HDB9 | |
| QAPQQTGAFPIQPFV | 616 | Q7LDI9 | |
| TGAFPIQPFVPQGFQ | 621 | Q7LDI9 | |
| IQPFVPQGFQGQQPP | 626 | Q7LDI9 | |
| PQGFQGQQPPLSQVF | 631 | Q7LDI9 | |
| QAPQQTGAFPIQPFV | 616 | P63130 | |
| TGAFPIQPFVPQGFQ | 621 | P63130 | |
| IQPFVPQGFQEQQPP | 626 | P63130 | |
| PQGFQEQQPPLSQVF | 631 | P63130 | |
| QAPQQTGAFPIQPFV | 616 | P62685 | |
| TGAFPIQPFVPQGFQ | 621 | P62685 | |
| IQPFVPQGFQDNNPH | 626 | P62685 | |
| QAPQQTGAFPIQPFV | 616 | P63126 | |
| TGAFPIQPFVPQGFQ | 621 | P63126 | |
| IQPFVPQGFQGQQPP | 626 | P63126 | |
| PQGFQGQQPPLSQVF | 631 | P63126 | |
| QAPQQTGAFPIQPFV | 616 | P62684 | |
| TGAFPIQPFVPQGFQ | 621 | P62684 | |
| IQPFVPQGFQGQQPP | 626 | P62684 | |
| PQGFQGQQPPLSQVF | 631 | P62684 | |
| EEPNAFGVNNPFLPQ | 31 | Q9UJJ9 | |
| PAFPQQVPLVQQGSR | 511 | Q6UUV7 | |
| GTFQVIPVPPNGENQ | 1916 | A8TX70 | |
| EGPGLPDFVFQQQPV | 26 | P78396 | |
| NFPDQFVQITDPTQP | 636 | O75976 | |
| FFSQQQPEQLVPGPG | 521 | O95479 | |
| QAPPTLPGIFVIQNQ | 826 | Q9NZM4 | |
| PTPPVQQPFQASFQA | 386 | O95104 | |
| IQFLWNPPPQQFING | 886 | Q7Z5N4 | |
| PAQPGPQEVFLQVLN | 406 | Q16348 | |
| IPNIFPANPANISVA | 346 | Q8IY34 | |
| PPAEQAQATQNVYVP | 526 | Q13029 | |
| PFQGNAFLTSQPVPV | 481 | P49757 | |
| GTFTLFLQPVDNQPP | 816 | P0C091 | |
| PTFQEPPVNPLGQFN | 136 | Q9H0K4 | |
| YTPNVVVGQVPPGTN | 486 | Q9UPN9 | |
| HLPPPGQFVPFQTQQ | 286 | Q9H0F5 | |
| TSPQQIPEQPNFADF | 616 | Q96D71 | |
| PPPAQTFLFQGQPVV | 196 | Q15628 | |
| PQTAPAQVPQGFNVF | 126 | Q9NYJ8 | |
| PTPAQPQSFSVGQPQ | 261 | O75157 | |
| VGAPAAQQPQQFAYP | 346 | O75157 | |
| FSQAVQNQPTPAQPG | 1296 | Q15788 | |
| PGVNVQITGLAFNPF | 461 | Q7Z443 | |
| FQPGLSQPTSVQQIP | 2416 | Q9Y520 | |
| APPVAPVQGQQQFQR | 106 | Q96ST3 | |
| PGVNPQAPFLQVAPN | 491 | Q9Y2K2 | |
| FQNENFQLQLIPPPV | 1411 | Q8N3P4 | |
| AQQQFTEPAFISPLP | 131 | E7EW31 | |
| QAPQQTGAFPIQPFV | 616 | P63128 | |
| TGAFPIQPFVPQGFQ | 621 | P63128 | |
| IQPFVPQGFQGQQPP | 626 | P63128 | |
| PQGFQGQQPPLSQVF | 631 | P63128 | |
| ATQAVPAPNQQPEVF | 21 | P05091 | |
| QQPAFPAQAAFPQQT | 491 | P52594 | |
| LFPPQTPLVQQQNGS | 421 | O95081 | |
| IINVPNPGSNQPAYV | 3611 | Q96T58 | |
| FGSPARPTFVIQPQN | 336 | Q92626 | |
| FLQENTQPVPLSGNP | 366 | Q2MV58 | |
| PSQQPQVEVYVNGIP | 1036 | Q86WI1 | |
| ITQPVAAQPGQPFPQ | 4086 | Q86WI1 | |
| PGAQPLFFGVAQPQV | 556 | Q96JG9 | |
| VFEAQSRPQGLPNPF | 751 | Q6PJI9 | |
| YQQPLAQVPVQGGQP | 236 | Q96PN7 | |
| NEFGVPPSPANFIQP | 431 | P19440 | |
| QVPAQVPSQDPFGLA | 2166 | O14686 | |
| RPNPPTFAQGVINEA | 3491 | O14686 | |
| MNSFQQQPPPFGTVP | 26 | P20592 |